Acarix AB (publ) (STO:ACARIX)

Market Cap	463.37M
Revenue (ttm)	6.38M
Net Income (ttm)	-65.37M
Shares Out	1.12B
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,223,169
Average Volume	3,218,097
Open	0.4135
Previous Close	0.4145
Day's Range	0.4000 - 0.4240
52-Week Range	0.1688 - 0.5990
Beta	1.15
RSI	68.52
Earnings Date	Aug 21, 2025

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX

Financial Performance

In 2024, Acarix AB's revenue was 6.20 million, a decrease of -0.62% compared to the previous year's 6.24 million. Losses were -66.19 million, -14.97% less than in 2023.